Disposable Syringes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Conventional Syringes, Safety Syringes), By End Use (Hospitals & Clinics, Ambulatory Care Centers, Diagnostic Centers, Others), By Region and Competition, 2020-2030F

Market Overview

Global Disposable Syringes Market was valued at USD 10.57 Billion in 2024 and is expected to reach USD 13.58 Billion by 2030 with a CAGR of 4.46%. Disposable syringes are widely used in hospitals, clinics, and home healthcare settings for the administration of vaccines, medications, and other injectable treatments. Their single-use design significantly reduces the risk of cross-contamination and transmission of infectious diseases, making them a critical component of modern healthcare delivery.

The market is benefiting from advancements in syringe design and manufacturing. Innovations such as auto-disable syringes, safety syringes, and prefilled syringes are gaining traction due to their enhanced safety features and ease of use. These technologies not only improve patient and healthcare worker safety but also align with global efforts to promote injection safety standards in both developed and developing regions. Despite the market's strong trajectory, several challenges persist. Environmental concerns related to the disposal of medical plastic waste, along with the rising costs of raw materials and production, continue to pose hurdles.

Key Market Drivers

Growth in Healthcare Industry

The global healthcare industry generates annual sales exceeding USD 4 trillion. Among its most lucrative segments are pharmaceuticals and biotechnology, accounting for nearly USD 850 billion, followed by medical technology and diagnostics, which contribute over USD 400 billion. The ongoing expansion of the global healthcare industry is a key driver of growth in the global disposable syringes market. As healthcare systems worldwide continue to evolve, there is a marked increase in demand for safe, efficient, and hygienic medical devices. Disposable syringes, being fundamental tools in the administration of vaccines, injectable medications, and other therapeutic agents, have witnessed a surge in demand driven by broader healthcare advancements.

One of the primary factors contributing to this growth is the rising global patient population and the increasing incidence of chronic and infectious diseases. In 2020, an estimated 523 million individuals globally were affected by some form of cardiovascular disease (CVD), with approximately 19 million deaths attributed to the condition. This accounted for around 32% of total global deaths and marked an absolute increase of 18.7% compared to 2010. Conditions such as diabetes, cardiovascular disorders, and various forms of cancer require frequent administration of injectable therapies, fueling the consumption of disposable syringes. At the same time, global immunization initiatives, particularly in developing nations, have led to widespread use of single-use syringes for vaccine delivery, further boosting market demand.

Surge in Technological Advancements

The global disposable syringes market is experiencing robust growth, strongly driven by a surge in technological advancements that are transforming syringe design, production processes, and safety features. The first disposable glass syringe, the Hypak syringe by BD, was introduced in 1954, followed by the launch of the first all-plastic syringe in 1955. To ensure the efficient performance of these plastic syringes, new technologies were developed such as the application of silicone oil to minimize friction between the plunger and the syringe barrel. These innovations are not only enhancing the efficiency and reliability of disposable syringes but are also addressing critical healthcare priorities such as infection control, patient safety, and ease of use.

One of the most significant technological breakthroughs in this market is the development of safety-engineered syringes. Innovations such as auto-disable syringes, retractable needle mechanisms, and needle-free injectors are reducing the risk of needlestick injuries and preventing the reuse of syringes, thereby playing a vital role in infection prevention, especially in high-risk and resource-limited settings. These safety features are increasingly being mandated by health authorities and supported by global immunization campaigns.

Download Free Sample Report

Key Market Challenges

High Cost of Safety-Engineered Syringes

The high cost of safety-engineered syringes presents a significant challenge in the global disposable syringes market, particularly in resource-constrained settings. While these syringes are designed to prevent needlestick injuries and reduce the risk of disease transmission, their advanced safety mechanisms come at a considerably higher price compared to standard disposable syringes. This cost disparity creates financial barriers for widespread adoption, especially in low- and middle-income countries where budget allocations for healthcare are often limited.

Safety-engineered syringes incorporate features such as retractable needles, auto-disable technology, or protective shielding, all of which enhance user safety but also increase manufacturing complexity and material usage. These added production requirements contribute to higher unit costs, which can strain procurement budgets in both public and private healthcare sectors. As a result, many healthcare facilities particularly those operating under tight financial constraints may opt for conventional, lower-cost alternatives despite the associated safety risks.

Key Market Trends

Rise of Biologics and Specialty Injections

The increasing adoption of biologics and specialty injections is emerging as a significant trend driving the evolution of the global disposable syringes market. The World Health Organization (WHO) acknowledges biosimilars as crucial in enhancing global access to essential biological therapies. By incorporating quality-assured biosimilars into its Essential Medicines List (EML), WHO affirms their safety, efficacy, and cost-effectiveness as viable alternatives to originator biologics. As the pharmaceutical landscape shifts toward more targeted, high-efficacy therapies, the demand for advanced injectable treatments particularly biologics has grown substantially. This trend has, in turn, elevated the need for reliable, high-quality disposable syringes tailored to the unique requirements of these formulations.

Biologic drugs, often used to treat chronic and complex conditions such as autoimmune diseases, cancers, and genetic disorders, are typically administered via subcutaneous or intravenous injection. Due to their molecular complexity and precise dosing requirements, these therapies demand syringes that ensure safety, sterility, and accurate delivery. As a result, manufacturers are innovating syringe designs to accommodate the viscosity and sensitivity of biologic compounds.

Segmental Insights

Product Insights

Based on Product, Conventional Syringes have emerged as the fastest growing segment in the Global Disposable Syringes Market in 2024. This is due to their widespread applicability, cost-effectiveness, and critical role in routine healthcare practices. Despite the increasing focus on advanced safety-engineered syringes, conventional syringes continue to dominate in volume, especially in developing regions where affordability and accessibility are key priorities. A major driver behind this growth is the rising demand for conventional syringes in mass vaccination programs, including seasonal flu and childhood immunization campaigns.

End Use Insights

Based on End Use, Hospitals & Clinics have emerged as the fastest growing segment in the Global Disposable Syringes Market during the forecast period. This is due to the increasing demand for infection control, rising patient volumes, and the expansion of healthcare infrastructure worldwide. As the global burden of chronic and infectious diseases continues to escalate, hospitals and clinics are performing a significantly higher number of procedures that require sterile, single-use syringes including immunizations, intravenous drug delivery, and diagnostic tests. The heightened emphasis on patient safety and the prevention of hospital-acquired infections has driven the widespread adoption of disposable syringes in clinical settings.

Download Free Sample Report

Regional Insights

Based on Region, North America have emerged as the dominating region in the Global Disposable Syringes Market in 2024. This is due to its advanced healthcare infrastructure, stringent regulatory standards, and strong demand for infection control practices. One of the primary drivers of this dominance is the well-established healthcare system across the United States and Canada, which ensures widespread adoption of high-quality medical devices, including single-use syringes. Hospitals, clinics, and ambulatory centers across the region prioritize patient safety and procedural efficiency, making disposable syringes the preferred choice for injections, vaccinations, and fluid administration.

Recent Development

• In March 2024, Hindustan Syringes and Medical Devices (HMD), a leading manufacturer of disposable and auto-disable syringes, announced the launch of Dispojekt, an indigenously developed single-use safety syringe aimed at minimizing the risk of needle stick injuries (NSIs) among healthcare professionals. With the introduction of Dispojekt, HMD intends to significantly improve occupational safety standards within medical settings, while also contributing to a reduction in infection control expenses, waste disposal costs, and training requirements. This initiative is expected to generate a long-term positive financial impact on the healthcare sector by enhancing both operational efficiency and patient care standards.
• In January 2024, medmix Drug Delivery (Haselmeier) unveiled its passive needle safety device, SicuroJect, at Pharmapack Europe in Paris, marking a strategic expansion of its product portfolio. SicuroJect is a disposable safety solution designed for subcutaneous injections, aimed at protecting patients, healthcare professionals, and caregivers from needlestick injuries post-use. The device is being developed in two configurations to accommodate standard 1 mL long and 2.25 mL pre-filled glass or plastic syringes. Haselmeier offers SicuroJect both as a ready-to-use product and as a comprehensive service platform, which can include combination product development, design verification, final assembly, secondary packaging, labeling, and serialization tailored to meet specific customer requirements.
• In March 2025, BD (Becton, Dickinson and Company), a global leader in medical technology, announced the launch of the BD Intevia 1mL two-step disposable autoinjector. This advanced platform device integrates an autoinjector and a pre-fillable syringe into a single, streamlined system. The BD Intevia autoinjector features a two-step, push-on-skin mechanism designed to deliver a wide range of drugs safely and efficiently, accommodating viscosities up to 35cP and fill volumes up to 1mL. Its innovative design allows pharmaceutical companies to utilize the device across various drug formulations without the need for system component customization.
• In April 2025, DDL, a leading provider of package, product, and material testing services, inaugurated a new Good Manufacturing Practice (GMP) laboratory focused exclusively on drug-device combination product testing. This strategic expansion significantly bolsters DDL’s ability to deliver regulatory-compliant testing solutions to the pharmaceutical, biotechnology, and combination product sectors. The facility will provide ICH stability testing, functional and mechanical performance assessments (aligned with ISO 11040 and ISO 11608), as well as simulated distribution testing, addressing the increasing demand for rigorous GMP testing of devices including auto-injectors, pre-filled syringes, inhalers, and other combination products. Equipped with advanced technology and staffed by a team of skilled engineers, DDL’s new lab is positioned to offer comprehensive testing services that meet FDA, ISO, and other international regulatory requirements.

Key Market Players

• Gerresheimer AG
• Baxter International Inc.
• Becton, Dickinson and Company
• B. Braun SE
• Cardinal Health, Inc.
• Schott AG
• Hindustan Syringes & Medical Devices Ltd
• Nipro Corporation
• Retractable Technologies Inc.
• Terumo Corporation

Report Scope

In this report, the Global Disposable Syringes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Disposable Syringes Market, By Product:

o   Conventional Syringes

o   Safety Syringes

• Disposable Syringes Market, By End Use:

o   Hospitals & Clinics

o   Ambulatory Care Centers

o   Diagnostic Centers

o   Others

• Disposable Syringes Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Disposable Syringes Market.

Available Customizations:

Global Disposable Syringes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Disposable Syringes Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]